A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: without difficulty (163), simply (108)

Bevacizumab(15mgkg) Carboplatin Gemcitabine (day1)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC4)-GEMCITABINE (day 1) This protocol may require funding Regimen • Ovary-Bevacizumab (15)-Carboplatin (AUC4)-Gemcitabine (1) Indication • Recurr
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab15mgkg-Carboplatin-Gemcitabine-day1.pdf

Papers Trust Board - 27 July 2023

Description
Date Time Location Chair Agenda Trust Board – Open Session 27/07/2023 9:00 - 13:15 Conference Room, Heartbeat/Microsoft Teams Jenni Douglas-T
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2023-Trust-documents/Papers-Trust-Board-27-July-2023.pdf

Medications to help the symptoms of an overactive bladder - patient information

Description
This factsheet provides information about taking antimuscarinic medications to help with the symptoms of an overactive bladder.
Url
/Media/UHS-website-2019/Patientinformation/Womenshealth/Medications-to-help-the-symptoms-of-an-overactive-bladder-1221-PIL.pdf

Carboplatin(AUC6)-Gemcitabine

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN (AUC6)-GEMCITABINE Regimen  NSCLC – Carboplatin (AUC6)-Gemcitabine Indication  First line therapy of stage III or IV NSC
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-AUC6-Gemcitabine.pdf

Carboplatin (AUC4.5) Gemcitabine

Description
Chemotherapy Protocol BLADDER CARBOPLATIN (AUC4.5)-GEMCITABINE Regimen  Bladder-Carboplatin-Gemcitabine Indication  Locally advanced or metastatic urothelial cancer  WHO performance status 0,1, 2  Palliative inte
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Carboplatin-AUC4.5-Gemcitabine.pdf

Carboplatin (AUC5)-Pegylated Liposomal Doxorubicin (Caelyx)x)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5) - DOXORUBICIN PEGYLATED LIPOSOMAL (Caelyx) Please note this protocol
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5-Pegylated-Liposomal-DoxorubicinCaelyxVer1.pdf

Double vision and Fresnel prisms - patient information

Description
The factsheet explains what double vision is and how it can be treated using Fresnel prisms.
Url
/Media/UHS-website-2019/Patientinformation/Eyes/Double-vision-and-Fresnel-prisms-3471-PIL.pdf

Hand therapy treatment for children with camptodactyly - patient information

Description
This factsheet explains what camptodactyly is and the types of hand therapy treatment available for children.
Url
/Media/UHS-website-2019/Patientinformation/Childhealth/Hand-therapy-treatment-for-children-with-camptodactyly-3474-PIL.pdf

Carboplatin (AUC4)-Gemcitabine (day 1, 8) Retreat

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC4)-GEMCITABINE (day 1, 8) Retreat Regimen • Ovary-Carboplatin (AUC4)-Gemcitabine (1, 8) Retreat Indication • Recurrent platinum sensitive ovarian cancer whe
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC4-Gemcitabineday18Retreat.pdf

CarboplatinAUC4-Gemcitabine (day 1,8)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC4)-GEMCITABINE (day 1, 8) Regimen  Ovary-Carboplatin (AUC4)-Gemcitabine (1, 8) Indication  Recurrent platinum sensitive ovarian cancer where re-treatment
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC4-Gemcitabine-day18.pdf
181 to 190 of 367
Previous … 17 18 19 20 21 … Next